Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants

NCT04167137 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Metastatic Solid Neoplasm
Lymphoma

Interventions

DRUG: SYNB1891
DRUG: Atezolizumab

Sponsor

Synlogic

Collaborators

[object Object]